General Information of the Compound
| Compound ID |
CP0479739
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
9-(4,6-dimethylpyrimidin-2-yl)-2-[(4-phenyl-1H-pyrazol-5-yl)methyl]-2,9-diazaspiro[5.5]undecan-1-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H30N6O
|
||||||||||||||||||
| Molecular Weight |
430.556
|
||||||||||||||||||
| Canonical SMILES |
Cc1cc(C)nc(n1)N1CCC2(CCCN(Cc3[nH]ncc3-c3ccccc3)C2=O)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H30N6O/c1-18-15-19(2)28-24(27-18)30-13-10-25(11-14-30)9-6-12-31(23(25)32)17-22-21(16-26-29-22)20-7-4-3-5-8-20/h3-5,7-8,15-16H,6,9-14,17H2,1-2H3,(H,26,29)
Show/Hide
|
||||||||||||||||||
| InChIKey |
OJNXCHMGWDYBOV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1